Cell fusion in the budding yeast Saccharomyces cerevisiae is a temporally and spatially regulated process that involves degradation of the septum, which is composed of cell wall material, and occurs between conjugating cells within a prezygote, followed by plasma membrane fusion. The plasma membrane protein Fus1p is known to be required for septum degradation during cell fusion, yet its role at the molecular level is not understood. We identified Sho1p, an osmosensor for the HOG MAPK pathway, as a binding partner for Fus1 in a two-hybrid screen. The Sho1p-Fus1p interaction occurs directly and is mediated through the Sho1p-SH3 domain and a proline-rich peptide ligand on the Fus1p COOH-terminal cytoplasmic region. The cell fusion defect associated with fus1⌬ mutants is suppressed by a sho1⌬ deletion allele, suggesting that Fus1p negatively regulates Sho1p signaling to ensure efficient cell fusion. A twohybrid matrix containing fusion proteins and pheromone response pathway signaling molecules reveals that Fus1p may participate in a complex network of interactions. In particular, the Fus1p cytoplasmic domain interacts with Chs5p, a protein required for secretion of specialized Chs3p-containing vesicles during bud development, and chs5⌬ mutants were defective in cell surface localization of Fus1p. The Fus1p cytoplasmic domain also interacts with the activated GTP-bound form of Cdc42p and the Fus1p-SH3 domain interacts with Bni1p, a yeast formin that participates in cell fusion and controls the assembly of actin cables to polarize secretion in response to Cdc42p signaling. Taken together, our results suggest that Fus1p acts as a scaffold for the assembly of a cell surface complex involved in polarized secretion of septum-degrading enzymes and inhibition of HOG pathway signaling to promote cell fusion.
M ATING yeast cells achieve cytoplasmic continuity
Several signaling pathways have been implicated in the regulation of cell fusion. Strains with reduced pherothrough a combination of degradation of the prezygote septum and fusion of the plasma membrane mone production accumulate prezygotes during mating, indicating that cell fusion is dependent upon a in a process termed cell fusion (Marsh and Rose 1997) . The mating reaction proceeds as an ordered set of critical pheromone level (Brizzio et al. 1996; Dorer et al. 1997) . The pheromone response pathway may also events (Sprague and Thorner 1992; Elion 2000) . First, mating partners, which are arrested in the G 1 phase of directly control cell fusion since mutations in FUS3, encoding the pheromone response mitogen-activated prothe cell cycle due to mating-pheromone-induced signaltein kinase (MAPK), lead to a fusion defect (Elion et ing, make contact and remodel their cell surface to form a al. 1990; Fujimura 1990) . Activated alleles of PKC1 inprezygote, in which two cells are joined by a continuous hibit cell fusion, implicating the PKC pathway in negaextracellular matrix while their plasma membranes retive regulation of cell fusion (Philips and Herskowitz main separated by an intervening septum. Second, local-1997) . Finally, high levels of internal glycerol relative ized degradation of the septum facilitates membrane to the external medium inhibit cell fusion (Philips and fusion, which requires the membrane-spanning protein Herskowitz 1997), which suggests that the HOG MAPK Prm1p (Heiman and Walter 2000) and leads to cytopathway, which increases production of glycerol in replasmic mixing. Finally, nuclear migration and nuclear sponse to high-osmotic conditions (Posas and Saito 1997), fusion leads to the formation of a diploid zygote that may also influence cell fusion. resumes vegetative growth.
The HOG pathway contains two major branches, each with its own surface-localized sensors, that feed into the MAPK kinase, Pbs2p, which activates the Hog1p MAPK 1 brane domains and a COOH-terminal SH3 domain enzyme involved in the assembly of the cell wall at the mother-bud junction and is maintained intracellularly (Maeda et al. 1995) . SH3 domain peptide recognition modules often occur within signaling molecules and by a Chs5p-dependent cycle of transport between the trans-Golgi network and early endosomes (Santos and bind to proline-rich peptide ligands on specific target proteins (Tong et al. 2002) . The COOH-terminal SH3 Snyder 1997; Ziman et al. 1998) . Thus, Chs5p is dedicated to a specialized secretory pathway during budding, domain of Sho1p binds the proline-rich ligand Pbs2p (Maeda et al. 1995) , which facilitates its cell surface and components of this pathway may be recruited to a fusion-specific pathway required for zygote formation localization and activation of the Hog1p MAPK (Raitt et al. 2000) .
during mating. Taken together, these studies provide a general model These various signaling pathways may control the activity of the fusion-specific proteins Fus1p and Fus2p, for regulation of prezygote septum degradation during cell fusion. A cell fusion signaling pathway, presumably whose expression is pheromone induced (McCaffrey et al. 1987; Trueheart et al. 1987) . Fus1p is a plasma originating with a stimulus generated within the cellcell contact region of the prezygote and transmitted or membrane protein with an external NH2-terminal O-glycosylated region, a single transmembrane domain, modulated by components of the pheromone response, PKC, and HOG MAPK pathways, activates Fus1p and and a larger cytoplasmic region containing a COOHterminal SH3 domain (Trueheart and Fink 1989) .
Fus2p-Rvs161p to control actin-based polarization machinery that directs secretion of specialized vesicles conFus1p localizes to the growing tip of mating projections and the cortical septum region of the prezygote. Fus2p taining a cargo of septum-degrading enzymes. To substantiate this model at the molecular level, we examined is an intracellular protein that binds Rvs161p, a homolog of mammalian amphiphysin, and, like Fus1p, both the role of a protein-protein interaction between Fus1p and the HOG MAPK pathway osmosensor Sho1p and Fus2p and Rvs161p localize to the shmoo tip and are required for cell fusion we generated a network of protein-protein interactions involving Fus1p, a number of other proteins implicated al . 1998) .
Electron microscopy has revealed some clues to the in cell fusion, and the components of the yeast pheromone response MAPK pathway. roles of fusion proteins; vesicles cluster along the zone of cell fusion in wild-type cells where cell wall thinning occurs show a striking absence of vesicles at the zone of cell all derivatives of W3031A 112 ura3-1 trp1-1 can1-100) and W3031B 15 fusion and appear to fall into the first class of mutants, . Because amphiphysin is ste12⌬::kanR leu2 his3 trp1 ade2 lys2 gal80 GAL4), which were able to bind lipid bilayers and remodel membranes, the used in two-hybrid experiments. We constructed W303 derivatives Y2106 Rvs161p-Fus2p pair may perform a similar role during URA3) and Y2108 cell fusion (Takei et al. 1999). through crosses between Y23 (MAT␣ far1-f3 sst1::LEU2), Y427 Bni1p, Pea2p, and Spa2p are also required for effi- (MATa fus1⌬::URA3) , and Y1668 (MATa ssk1⌬::HIS3MX6). cient cell fusion (Dorer et al. 1997) . These proteins Y23 (MAT␣ far1-f3 sst1::LEU2) was constructed by transform a complex that regulates polarized cell growth forming SY2624 (MAT␣ far1-f3) with HindIII-BamHI-digested pZV77 (sst1::LEU2). SY2624 (MAT␣ far1-f3) was constructed by in response to signals involving the Cdc42p Rho-type transformation of a W3031B-derived strain with EcoRI-digested GTPase (Chenevert et al. 1994; Amberg et al. 1997;  pSL2287 (far1-f3); transformants were then streaked onto Evangelista et al. 1997; Sheu et al. 1998) . Bni1p and quired for the assembly of tropomyosin-stabilized actin Y1668 (MATa ssk1⌬::HIS3MX6) was constructed by replacing cables Sagot et al. 2002) .
the SSK1 protein-coding sequence with a HIS3MX6 cassette Actin cables probably act as tracks for type V myosin (Longtine et al. 1998) . To construct Y579 (MATa fus1⌬:: motors, which direct the trafficking of secretory vesicles. SmaI-digested p1288 [URA3 to LEU2 switcher plasmid Consistent with the role of these proteins in polarized (Cross 1997) ] was transformed into Y427, which was then backcrossed to a W3031B derivative to create Y2816 (MAT␣ secretion, spa2⌬ mutants contain vesicles that fail to fus1⌬::LEU2). Y1657 (MAT␣ sho1⌬::TRP1MX6) was constructed cluster in a polarized manner .
LEU2),
by replacing the SHO1 protein-coding sequence with TRP1MX6
Chs5p plays a role in cell fusion that, by analogy to its and the resultant strain was backcrossed to generate Y2653 (MATa role in Chs3p trafficking and localization during budsho1⌬::TRP1MX6). Y2601 (MATa ssk1⌬::HIS3MX6 sho1⌬::TRP1 ding, may involve a cell-fusion-specific secretory pathway MX6) and Y2602 (MAT␣ ssk1⌬::HIS3MX6 sho1⌬::TRP1MX6) were constructed by crossing Y1657 (MAT␣ sho1⌬::TRP1MX6) (Dorer et al. 1997; . Chs3p is an and Y1668 (MATa ssk1⌬::HIS3MX6) . Y1690 (MATa sho1⌬::TRP1 a 5Ј-EcoRI site and 3Ј-XhoI site; p458 encodes Cdc42p that incorporates a C188S substitution, preventing prenylation, MX6 fus1⌬::LEU2) and Y1691 (MAT␣ sho1⌬::TRP1MX6 fus1⌬:: URA3) were constructed by crossing Y448 (MATa fus1⌬::LEU2) and a G12V mutation, which locks Cdc42p into the GTPbound state (Stevenson et al. 1995) ; p701 encodes Cdc42p and Y1657 (MAT␣ sho1⌬::TRP1MX6) . To construct Y1005 (MATa chs5⌬::TRP1 sst1⌬), SY2625 (MATa sst1⌬) was transformed that incorporates a C188S substitution, preventing prenylation, and a D188A mutation locking Cdc42p into the GDPwith XhoI-SstI-digested p220 (chs5⌬::URA3) to produce Y374 (MATa chs5⌬::URA3 sst1⌬), which was then transformed with bound state (Stevenson et al. 1995 ; p2155 encodes full-length Rvs161p; p2273 enmedium and screened for a fusion defect. To create Y2813 (MATa fus1⌬ sst1⌬ spa2⌬::LEU2), Y334 was transformed with codes Chs5p (1-261) and incorporates a 5Ј-EcoRI site and a 3Ј-XhoI site; p464 encodes an AD-Cdc42p fusion that incorpoSal I-HindIII-digested p219 (spa2⌬::URA3) to produce Y2657 (MATa fus1⌬ sst1⌬ spa2⌬::URA3), which was transformed with rates a C188S substitution, preventing prenylation, and a G12V mutation, which locks Cdc42p in a GTP-bound state (StevenSmaI-digested p1288 [URA3 to LEU2 switcher plasmid (Cross 1997)].
son et al. 1995); p461 encodes Rga1p (provided by John Pringle); p993 encodes full-length Far1p (Butty et al. 1998) ; Plasmid construction: The following plasmids were used: p307, which encodes a fus1⌬::URA3 plasmid; pSL1475, which p2106 encodes Bnr1p (1-753) and incorporates a 5Ј-Sal I; p2098 encodes Bnr1p (754-1376) and incorporates a 3Ј-Sal I encodes a fus1⌬ URA3-based yeast integrating plasmid (YIP); pSL1851, which encodes a ste4⌬::URA3 plasmid; pSL2068, site; p2099 encodes Bnr1p (856-1376) and incorporates a 5Ј-Sal I; p3503 encodes Sho1p-SH3 (280-368); p3492 encodes which encodes a far1⌬::URA3 plasmid; and pSL2287, which encodes a far1-f3::URA3 YIP plasmid, provided by George Sho1p-SH3 (281-368) with a P352A mutation, Sho1p-SH3 (P352A), and was created in a two-step PCR procedure (primSprague. pZV77, a sst1::LEU2 plasmid, was provided by Vivian Mackay. pMA106 (RAS2-GFP), a CEN TRP1 vector, derived ers available upon request). The following pACT-derived AD plasmids (Durfee et al. 1993) were all obtained from G. from YCplac22, carrying a RAS2-GFP fusion gene, was provided by Jennifer Whistler and Jasper Rine. p1287, a URA3 to HIS3 Sprague (Printen and Sprague 1994): p1422 encodes Ste4p, p1423 encodes Ste11p, p1426 encodes Kss1p, p1428 encodes switcher plasmid, p1288, a URA3 to LEU2 switcher plasmid, and p1289, a URA3 to TRP1 switcher plasmid, were provided Ste7p, p1432 encodes Ste5p, p1435 encodes Fus3p, p1438 encodes Ste20p, and p1487 encodes Ste12p. p1517 encodes by Fred Cross (Cross 1997). To create p220 (chs5⌬::URA3), an XhoI-Bgl II fragment from p181(CHS5 in pRS316, Sikorski Gpa1p(R297A) in pGAD3F, and the R297A mutation should lock Gpa1p in a GTP-bound state. p628 encodes Fus1p (97-and Hieter 1989) was cloned into KSϩ (Stratagene, La Jolla, CA) and a URA3 fragment was inserted into the BamHI sites 513) in pACT-derived plasmids (Amberg et al. 1997) . p2073 encodes Spa2p (1-1466), p2074 encodes Spa2p (743-1466), within CHS5; this deleted the CHS5 sequence encoding amino acids 98-181 and left the downstream CHS5 sequence out of and p2075 encodes Spa2p (512-1118), all in pACT-derived plasmids obtained from M. Snyder (Sheu et al. 1998) . p500 frame. To create p219 (spa2⌬::URA3), a Sal I-HindIII fragment from p185 (spa2⌬::URA3 in YCp50, provided by Nicole Valtz) encodes an AD-Cdc24p fusion in a pACT-derived plasmid (a gift from Alan Bender); p831 encodes Bud6p (274-789) in was cloned into KSϩ (Stratagene). p2226, carrying ADH1-BNI1-GFP, was created in two steps. First, p532 (Evangelista a pACT-derived plasmid (Evangelista et al. 1997) ; p1124 encodes Act1p (Evangelista et al. 1997); and p1586 encodes et al. 1997) , carrying full-length BNI1 with a BamHI site immediately 5Ј to the start ATG, was cut with BamHI-NotI and ligated full-length Pea2p in pGAD-C. To create p3998 encoding GST-Sho1p (281-368) with a into a pRS316-based vector carrying the ADH1 promoter to produce p2224. Second, a 500-bp NheI to NotI fragment of P352A mutation, the insert from p3492 was ligated in frame with the GST sequences of pGEX-3X (Pharmacia). To create p1912 , carrying BNI1-GFP behind its own promoter, was ligated into p2224 to produce p2226. p3999 encoding Sho1p (281-368), the insert from p3503 was ligated in frame with the GST sequences of pGEX-3X (PharTwo-hybrid constructs were based on pEG202 (Gyuris et al. 1993 ) and pBTM116 (Hollenberg et al. 1995) encoding macia). p4040, encoding MBP-Fus1p (96-513), was created by ligation of a FUS1 PCR fragment in frame with the maltose the LexA-DNA binding domain (DBD), and pJG4-5 (Gyuris et al. 1993) , pACT (Durfee et al. 1993) , and pGAD-C ( James binding protein (MBP) sequences of pMAL-c2 (New England Biolabs, Beverly, MA). et al. 1996) encoding a transcriptional-activation (AD) domain. DNA fragments of various genes were amplified by the polyp4263 is a pRS316 (Cen URA3)-based plasmid (Sikorski and Hieter 1989) carrying a gene encoding Fus1p(P422A), merase chain reaction (PCR) with primers that incorporated 5Ј-BamHI and 3Ј-NotI (unless otherwise stated) restriction sites driven by 800 bp of the FUS1 promoter, and was created in a two-step PCR procedure (primers available upon request). for insertion into the vectors. DBD plasmids were pEG202 unless otherwise stated: p1002 encodes Fus1p (97-513) and p4597 is a pRS314 (Cen TRP1)-based plasmid (Sikorski and Hieter 1989) encoding Fus1p-SH3(W473S), driven by 800 incorporates a 3Ј-XhoI site; p2100 encodes Fus1p (401-513); p1450 encodes full-length Fus2p; p1795 encodes full-length bp of the FUS1 promoter, and was created in a two-step PCR procedure (primers available upon request). p4598 is a Fus3p; p810 contains a Bni1p (1-1214) BamHI-NotI fragment cut from p717 (Evangelista et al. 1997) ; p813 encodes Bni1p pRS314 (Cen TRP1)-based plasmid encoding Fus1p (P422A)-SH3(W473S), driven by 800 bp of the FUS1 promoter, and (1414-1953); p890 encodes Bni1p (1227-1397); p2086 encodes full-length Pea2p; p1272 encodes full-length Rvs161p was created in a two-step PCR procedure. Similarly, we created a set of pRS316 (Cen URA3) plasmids encoding full-length in pBTM116; p2276 encodes Chs5p (1-261) and incorporates Pbs2p MAPK kinase (Maeda et al. 1995) and binds of one of the proline residues, Fus1p(P422A), which (Table 1) . These results suggest Y1356) were cotransformed with DBD and AD plasmids, and cells were grown in liquid culture to mid-log phase and then that binding between Fus1p and Sho1p is mediated assayed for expression of lexAop-lacZ as described (Hagen et through the Sho1p-SH3 domain and its consensus li- tion. In a previous study, we identified the SH3 domain of the Fus1p sequesters Sho1p during pheromone response: HOG MAPK pathway osmosensor Sho1p as a binding
The HOG pathway contains two distinct arms, both of partner for the cytoplasmic COOH-tail of the cell fusion which activate the MAPK kinase, Pbs2p, in response protein Fus1p in a two-hybrid screen (Tong et al. 2002) .
to hyperosmotic shock. Removal of either arm of the By phage display, we found that Sho1p-SH3 binds a pathway still allows cells to respond to high-osmotic conditions; removal of both arms renders cells defective K/RxLPxxP consensus ligand (Tong et al. 2002) . A pep-2000). These results suggest that Fus1p sequesters Sho1p away from Pbs2p in pheromone-responding cells.
The Sho1p-Fus1p interaction is required for efficient cell fusion and the Fus1p-SH3 domain contributes to cell fusion: To determine if disruption of the Sho1p-Fus1p interaction affects cell fusion, we introduced a plasmid that encodes a full-length consensus ligand mutant Fus1p(P422A) into a fus1⌬ deletion mutant strain and scored cell fusion efficiency in mating assays. Relative to a FUS1 wt ϫ wt control, cells expressing Fus1p (P422A) were compromised for cell fusion in both unilateral (wt ϫ mutant) and bilateral (mutant ϫ mutant) mating assays (77.1 Ϯ 1.8% of mating pairs were fused growing shmoo tip ( Figure 5 ), as observed for a Fus1p-GFP fusion that appears to be fully functional in mating assays (data not shown). These findings indicate that for growth in high osmolarity. To test whether Sho1p the Sho1p-Fus1p complex promotes cell fusion. bound Fus1p in vivo during pheromone response, we
The reduced fusion efficiency associated with Fus1p first constructed a strain missing SSK1 to force all high-(P422A) cells was less than the reduction seen for cells osmotic response to initiate from the Sho1p branch of lacking Fus1p altogether (fus1⌬; Figure 4A ), suggesting the HOG pathway and, containing a far1-f3 mutation that other domains of Fus1p are functionally important. (Peter et al. 1993) , to render the cells defective for
To test if the Fus1p-SH3 domain contributes to efficient pheromone-induced G 1 arrest. When ssk1⌬ far1-f3 cells cell fusion, a construct encoding full-length Fus1p-are transferred to a medium of high osmolarity, Sho1p-SH3(W473S) was introduced into fus1⌬ cells and fusion Pbs2p interaction is required for cells to respond to the efficiency was monitored in mating assays. Fus1p-high osmolarity and grow, but if Fus1p sequesters Sho1p SH3(W473S) was also expressed at normal levels and away from Pbs2p, Pbs2p activation will be prevented, localized to the growing shmoo tip ( Figure 5 ). Fus1p-resulting in a halo of growth inhibition caused by a SH3(W473S) cells were compromised for cell fusion in defect in Hog pathway signaling (Figure 2) . Indeed, both unilateral and bilateral mating assays (72.4 Ϯ 3.2% within a pheromone diffusion halo, MATa ssk1⌬ far1-f3
were fused in the control and 54.3 Ϯ 3.1% and 35.0 Ϯ failed to grow on high-osmolarity medium. In contrast, 1.6% in unilateral and bilateral assays, respectively; Figcells outside the halo grew normally due to a lack of ure 4A). Thus, the Fus1p-SH3 domain also mediates the pheromone-induced Fus1p expression (Figure 3 ). This formation of a complex important for cell fusion. pheromone-induced growth defect was dependent on A version of Fus1p containing both the P422A and Fus1p expression, because MATa ssk1⌬ far1-f3 fus1⌬ cells the W473S mutations, Fus1p(P422A)-SH3(W473S), was continued to divide, adhere to one another, and invade expressed and localized normally ( Figure 5 ), but was into the agar in the presence of pheromone in a process associated with a more pronounced fusion defect than was either single mutant alone (72.4 Ϯ 3.2% were fused known as pheromone-induced invasion (Roberts et al. cells fused normally, if not slightly more efficiently than wild-type cells in bilateral assays (74.5 Ϯ 4.8% were fused in the control and 73.3 Ϯ 6.5% and 83.3 Ϯ 8.3% in unilateral and bilateral mating assays, respectively; Figure 4B) . We conclude that Sho1p is not required for cell fusion.
To assay components of the other arm of the HOG pathway for a role in cell fusion, we examined a sho1⌬ ssk1⌬ double mutant in mating assays. The sho1⌬ssk1⌬ double mutant also appeared to fuse slightly more effi- If Sho1p negatively regulates cell fusion and Fus1p normally binds and inhibits Sho1p, then a sho1⌬ mutain the control and 26.8 Ϯ 1.0% and 15.6 Ϯ 1.1% in tion should at least partially alleviate the fusion defect unilateral and bilateral assays, respectively; Figure 4A ).
in fus1⌬ cells. Indeed, sho1⌬ suppressed the fusion deBecause this fusion defect was not as severe as that fect of fus1⌬ cells (fusion efficiency was 27.9 Ϯ 7.2% associated with the fus1⌬ deletion mutant (81.5 Ϯ 3.3%
for fus1⌬ cells and 50.0 Ϯ 4.6% for fus1⌬sho1⌬ cells in were fused in the control and 27.9 Ϯ 7.2% and 0.7 Ϯ unilateral assays; 0.7 Ϯ 0.6% for fus1⌬ cells and 8.8 Ϯ 0.6% in unilateral and bilateral assays, respectively), ad-1.6% for fus1⌬sho1⌬ cells in bilateral assays; Figure 4B ). ditional Fus1p domains may contribute to its function.
Furthermore, the fusion defect of Fus1p(P422A) was An inhibitory role for Sho1p in cell fusion: If Sho1p is completely suppressed in sho1⌬ cells, thereby demonrequired to promote cell fusion, then sho1⌬ cells should strating the dependence of Sho1p binding during fusion (data not shown). Thus, Fus1p sequestration repredisplay a fusion defect. However, we found that sho1⌬ For each experiment, a wt ϫ wt control assay, a unilateral or mutant ϫ wt assay, and a bilateral or mutant ϫ mutant fusion assay was performed simultaneously. The wt ϫ wt control processed with Fus1p(P422A) unilateral and bilateral fusion assays is the leftmost bar, the wt ϫ wt control processed with the Fus1p-SH3(W473S) assays is the second bar from the left, the wt ϫ wt control processed with Fus1p(P422A)-SH3(W473S) assays is the third bar from the left, and the wt ϫ wt control processed with fus1⌬ assays is the rightmost bar. The strains used were wild type (W3031A, W3031B) and fus1⌬ (Y579, Y2816). (B) Effect of Sho1p on fusion efficiency. The strains used in the fusion assays were wild type (W3031A, W3031B), fus1⌬ (Y579, Y2816), sho1⌬ (Y2653, Y1657), sho1⌬ ssk1⌬ (Y2601, Y2602), and sho1⌬ fus1⌬ (Y1690, Y1691) . sents a negative regulation of Sho1p, which appears to ther the SH3-dependent interactions are indirect or a different ligand mediates the protein-protein interacinhibit cell fusion. The finding that sho1⌬ did not fully suppress the fus1⌬ fusion defect suggests that Fus1p tions in vivo. Nevertheless, these findings suggest that the Fus1p-SH3 domain may mediate a complex with has an additional role(s) during fusion, perhaps one involving a Fus1p-SH3-mediated complex.
Bni1p to control actin cable assembly and regulate polarized secretion during cell fusion. Two-hybrid matrix reveals a network of fusion protein interactions: To identify additional Fus1p-binding part-CHS5 controls Fus1p localization: Chs5p is required for cell fusion in addition to the specialized secretion ners, we constructed a matrix of pairwise two-hybrid tests (Uetz et al. 2000) in which the fusion proteins of Chs3p vesicles during bud development (Dorer et al. 1997; Santos and Snyder 1997) . were tested for interactions with components of the pheromone response pathway, polarity proteins, and Since Chs5p showed a two-hybrid interaction with Fus1p ( Figure 6A ), we tested Chs5p for a role in targeting each other. The positive interactions, most of which have not been observed previously, were quantified on Fus1p-GFP to the tip of shmooing cells. In wild-type cells, Fus1p-GFP, which functions normally in cell fusion the basis of expression of a lacZ two-hybrid reporter and represented as fold induction with respect to a control assays (data not shown), was found concentrated in shmoo tips in 99.7 Ϯ 0.4% of cells (Figure 7) . In chs5⌬ lacking the activation domain fusion ( Figure 6A ). Visualization of these interactions as a network ( Figure 6B ) cells, the Fus1p-GFP signal appeared fainter and concentrated at shmoo tips in only 44.7 Ϯ 3.6% of the cells revealed that Fus1p showed an interaction with Fus2p and that both Fus1p and Fus2p showed interactions with examined. Western blot analysis revealed that the same amount of Fus1p-GFP protein was made in both wt and Fus3p, Bni1p, Pea2p, and the activated GTP-bound form of Cdc42p. Because all of these proteins localize to the chs5⌬ cells (data not shown). We infer that the fainter Fus1p-GFP signal in chs5⌬ cells may reflect the lack of growing shmoo tip, Fus1p and Fus2p may function as scaffolds for assembly of signaling and polarity proteins a concentrated localization of this protein in chs5⌬ cells. Evidence for the formation of a functional Fus1p-that control cell fusion. Two-hybrid tests comparing interactions with Fus1p-SH3 with Fus1p-SH3(W473S) Bni1p complex: Bni1p localizes to the sites of surface growth during budding and mating (Evangelista et indicated that interactions with Bni1p were SH3 dependent (Table 1) . Phage display analysis identified a Fus1p-al. 1997) . In budding cells, a Spa2p-Bni1p interaction appears to contribute to Bni1p localization, because SH3 consensus ligand (RxxRs/ts/tSl; Tong et al. 2002) , but none of these potential Fus1p-SH3 targets contained a substantial fraction of spa2⌬ deletion mutant cells mislocalize Bni1p (Fujiwara et al. 1998) . In shmooing a perfect match to this consensus ligand; therefore, ei- cells, however, an additional protein-protein interaction tion in fus1⌬ cells and fus1⌬ spa2⌬ double-mutant cells may contribute to the localization of Bni1p because and found that Bni1p-GFP localized normally to the almost all spa2⌬ cells scored (97.1 Ϯ 1.4%) showed growing tip of most fus1⌬ shmoos scored (96.9 Ϯ 0.5%). normal localization of Bni1p-GFP, which is comparable However, Bni1p-GFP localized correctly only in a subset to that observed for wt cells (99.4 Ϯ 0.8%; Figure 8 , A of the fus1⌬ spa2⌬ cells scored (53.5 Ϯ 4.7%; Figure  and B ). Since we observed a Fus1p-SH3-dependent two-8, A and B). Thus, both Fus1p and Spa2p appear to hybrid interaction between Fus1p and Bni1p, we tested contribute to Bni1p localization during pheromone rewhether pheromone-induced Fus1p contributed to sponse. Bni1p localization. We examined Bni1p-GFP localiza-
DISCUSSION
Our results suggest that Fus1p binds a number of different signaling, fusion, and polarity proteins and may act as a scaffold protein to coordinate multiple aspects of the cell fusion process. We found that a peptide in the Fus1p cytoplasmic domain binds to the SH3 domain of Sho1p, an osmosensor for the HOG MAPK pathway (Maeda et al. 1995) , which controls glycerol production and the osmotic state of the cell. Previous work established that the osmotic balance can regulate can inhibit cell fusion. Our results suggest a molecular model for negative regulation of cell fusion by osmo-A two-hybrid matrix analysis of cell fusion and signaling proteins showed that Fus1p interacts with several sensor signaling. Specifically, Sho1p appears to block cell fusion in the absence of Fus1p, and pheromonefusion and polarity proteins. In particular, we identified a Fus1p-Chs5p interaction and found that Chs5p coninduced expression of Fus1p prevents Sho1p from signaling HOG MAPK-dependent growth on high-osmolartrolled Fus1p localization to the growing mating projection, suggesting that Fus1p may be localized by a speciality medium. Thus, Fus1p appears to compete with the HOG MAPKK Pbs2p for binding to Sho1p (Figure 2) . ized secretory pathway in a manner similar to Chs3p localization. Recently, Santos and Snyder showed that Downregulation of Sho1p signaling by Fus1p may enable cells to lower their internal osmolarity, which would the role of Chs5p in cell fusion is specific to Fus1p, as Chs5p is not required for localization of other fusion reduce the chance of cell lysis and death during cell fusion. The HOG pathway contains at least two other proteins, such as Fus2p and Spa2p (Santos and Snyder 2003) . Our two-hybrid matrix revealed that the Fus1p-osmosensors in addition to Sho1p: Sln1p, which controls the Ssk1p branch , and SH3 domain binds to the NH2-terminal regulatory domain of Bni1p, a formin protein that controls nucleation Msb2p, which appears to be partially redundant with Sho1p (O'Rourke and Herskowitz 2002). Therefore, of actin cables, which determine polarized secretion and morphogenesis ; Sagot et additional modes of pheromone-induced negative regulation of HOG pathway signaling may also occur. . The regulatory domain of formins is known to be involved in their localization and negative regulaanalysis of Hog1p activation or intracellular glycerol levels during pheromone response and during zygote tion of their actin nucleation activity (Evangelista et al. 2003) . The Fus1p-Bni1p interaction is important for formation may further substantiate our model.
The PKC pathway is activated during projection forthe localization of Bni1p, as Fus1p appears to collaborate with Spa2p to concentrate Bni1p at the cortical mation and likely remains so until cell contact has been achieved (Zarzov et al. 1996; Buehrer and Errede 1997;  shmoo tip. Fus1p also interacts with the pheromone response MAPK Fus3p, which is required for cell fusion Roberts et al. 2000) . Activated alleles of PKC1 inhibit cell fusion, suggesting that the PKC pathway must be and thought to regulate the process Fujimura 1990) , suggesting that Fus1p may be regudownregulated before cell fusion can proceed (Philips and Herskowitz 1997) . Because a two-hybrid screen lated by Fus3p phosphorylation. The activated GTPbound form of Cdc42p interacted with Fus1p and subsewith a Fus1p bait identified interactions with both Sho1p and Pkc1p (Tong et al. 2002) , there is the potential for quent testing of cdc42-6, an allele defective in exocytosis (Adamo et al. 2001) , showed a requirement for Cdc42p coordinate regulation of multiple MAP kinase pathways through Fus1p complexes.
during cell fusion (data not shown). Finally, Fus1p
